{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:48:53Z","timestamp":1786121333739,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM115428"],"award-info":[{"award-number":["U54 GM115428"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL27255"],"award-info":[{"award-number":["R01 HL27255"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK06995"],"award-info":[{"award-number":["R01 DK06995"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK43140"],"award-info":[{"award-number":["R01 DK43140"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.steroids.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T23:30:26Z","timestamp":1504222226000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development of monoclonal antibodies against the human 3\u03b2-hydroxysteroid dehydrogenase\/isomerase isozymes"],"prefix":"10.1016","volume":"127","author":[{"given":"Celso E.","family":"Gomez-Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maniselvan","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise P.","family":"Gomez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.steroids.2017.08.011_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.steroids.2017.08.011_b0010","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1074\/jbc.M111.333278","article-title":"Mitochondrial 3beta-hydroxysteroid dehydrogenase enzyme activity requires reversible pH-dependent conformational change at the intermembrane space","volume":"287","author":"Prasad","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.011_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2002-0050","article-title":"Molecular biology of the 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase gene family","volume":"26","author":"Simard","year":"2005","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.011_b0020","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2013-3279","article-title":"Isoform-specific monoclonal antibodies against 3beta-hydroxysteroid dehydrogenase\/isomerase family provide markers for subclassification of human primary aldosteronism","volume":"99","author":"Doi","year":"2014","journal-title":"J. Clin. Endocrinology Metab."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.011_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm.2061","article-title":"Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6","volume":"16","author":"Doi","year":"2010","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.011_b0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11906-011-0181-3","article-title":"Hypertension due to loss of clock: novel insight from the molecular analysis of Cry1\/Cry2-deleted mice","volume":"13","author":"Okamura","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.steroids.2017.08.011_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.mce.2014.10.008","article-title":"3beta-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma","volume":"408","author":"Konosu-Fukaya","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2017.08.011_b0040","first-page":"322","article-title":"A single-step technique for selecting and cloning hybridomas for monoclonal antibody production","volume":"121","author":"Davis","year":"1986","journal-title":"Methods Enzymol."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2017.08.011_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2017.08.011_b0050","article-title":"G protein-coupled receptor expression in the adult and fetal adrenal glands","author":"Xing","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.011_b0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.steroids.2017.08.011_b0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/hr.2013.143","article-title":"Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice","volume":"37","author":"Nugrahaningsih","year":"2014","journal-title":"Hypertens. Res.: Official J. Jpn. Soc. Hypertens."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.011_b0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/ERC-120016825","article-title":"Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y","volume":"28","author":"Thomas","year":"2002","journal-title":"Endocr. Res."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:26:17Z","timestamp":1786076777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X17301435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":13,"alternative-id":["S0039128X17301435"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.08.011","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of monoclonal antibodies against the human 3\u03b2-hydroxysteroid dehydrogenase\/isomerase isozymes","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}